Shreyas Interm.

  • Market Cap: Micro Cap
  • Industry: Commodity Chemicals
  • ISIN: INE115F01017
  • NSEID:
  • BSEID: 526335
INR
10.80
0.5 (4.85%)
BSENSE

Dec 05

BSE+NSE Vol: 7.36 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

52 Week

Valuation
Technical
Day's Volume

CASH

7.36 k (1.78%) Volume

Shareholding (Sep 2025)

FII

8.42%

Held by 1 FIIs

DII

-0.00%

Held by 1 DIIs

Promoter

57.21%

Who are in the management team of Shreyas Interm.?

06-Jun-2025

As of March 2022, the management team of Shreyas Interm. includes Govind Krishna Sharma (Independent Director), Surya Prakash Pandey (Whole-time Director), Neelam Yashpal Arora (Independent Director), Bhavesh Vrujlal Gondaliya (Company Secretary & Compliance Officer), Dinesh Shankarlal Sharma (Non-Executive Director), and Nainesh Sumanti Rai Desai (Independent Director).

As of March 2022, the management team of Shreyas Interm. includes the following individuals:<BR><BR>1. Govind Krishna Sharma - Independent Director<BR>2. Surya Prakash Pandey - Whole-time Director<BR>3. Neelam Yashpal Arora - Independent Director<BR>4. Bhavesh Vrujlal Gondaliya - Company Secretary & Compliance Officer<BR>5. Dinesh Shankarlal Sharma - Non-Executive Director<BR>6. Nainesh Sumanti Rai Desai - Independent Director<BR><BR>These members play various roles within the company's governance and management structure.

Read More

Has Shreyas Interm. declared dividend?

06-Jun-2025

No Dividend History Available

Who are the peers of the Shreyas Interm.?

03-Jun-2025

Shreyas Interm.'s peers include Tata Chemicals, Chemplast Sanmar, GHCL, India Glycols, Fischer Medical, Sh. Hari Chem., Gayatri BioOrga., Genus Prime, and Camex. In terms of returns, India Glycols leads with 150.27% over one year, while Shreyas Interm. has a return of -9.56%.

Peers: The peers of Shreyas Interm. are Tata Chemicals, Chemplast Sanmar, GHCL, India Glycols, Fischer Medical, Sh. Hari Chem., Gayatri BioOrga., Genus Prime, and Camex.<BR><BR>Quality Snapshot: Excellent management risk is observed at GHCL, while Good management risk is found at Chemplast Sanmar and Sh. Hari Chem., and Average management risk is noted at Tata Chemicals and India Glycols. Below Average management risk is present at Fischer Medical and Camex, while Gayatri BioOrga., Genus Prime, and Shreyas Interm. do not qualify. Growth is Good at Sh. Hari Chem., while Below Average growth is seen at Tata Chemicals, Chemplast Sanmar, GHCL, India Glycols, and Camex. Average growth is noted at Fischer Medical, and the rest do not qualify. Capital Structure is Excellent at GHCL, Good at Fischer Medical, Average at Tata Chemicals, and Below Average at Chemplast Sanmar, India Glycols, Sh. Hari Chem., and Camex, while the rest do not qualify.<BR><BR>Return Snapshot: The peer with the highest 1-year return is India Glycols at 150.27%, while the lowest is Tata Chemicals at -14.63%. Shreyas Interm.'s 1-year return is -9.56%, which is higher than Tata Chemicals but lower than the majority of its peers. Additionally, Camex and Tata Chemicals have negative six-month returns.

Read More

Is Shreyas Interm. overvalued or undervalued?

09-Jun-2025

As of April 25, 2023, Shreyas Interm. is considered risky and overvalued due to negative earnings and unfavorable financial metrics, including a PE ratio of -42.92, while its year-to-date performance shows a decline of 23.72% compared to the Sensex's gain of 5.65%.

As of 25 April 2023, the valuation grade for Shreyas Interm. has moved from does not qualify to risky, indicating a significant change in its perceived financial health. The company appears to be overvalued based on its current metrics, with a PE ratio of -42.92, an EV to EBITDA of -75.07, and a Price to Book Value of 3.95. These ratios highlight the company's struggles, particularly with negative earnings and returns on capital employed and equity, which stand at -8.56% and -9.20%, respectively.<BR><BR>In comparison to its peers, Shreyas Interm. is positioned unfavorably against companies like Sudarshan Chemicals, which has a PE ratio of 71.32, and Kiri Industries, with a PE ratio of 13.72. This stark contrast further emphasizes the overvaluation of Shreyas Interm. Additionally, while the stock has shown a positive return of 3.85% over the past week compared to the Sensex's 1.45%, its year-to-date performance is concerning, with a decline of 23.72% against the Sensex's gain of 5.65%. Overall, the financial indicators suggest that Shreyas Interm. is overvalued in the current market environment.

Read More

What is the technical trend for Shreyas Interm.?

09-Jun-2025

As of June 4, 2025, Shreyas Interm. shows a mildly bearish trend overall, with mixed signals from various indicators, including a mildly bullish weekly MACD and bearish monthly MACD.

As of 4 June 2025, the technical trend for Shreyas Interm. has changed from bearish to mildly bearish. The weekly MACD indicates a mildly bullish stance, while the monthly MACD remains bearish. The daily moving averages are mildly bearish, suggesting short-term weakness. The Bollinger Bands show a bullish signal on the weekly timeframe but are mildly bearish on the monthly. The KST indicates a mildly bullish trend weekly, but is mildly bearish monthly. Overall, the indicators present a mildly bearish stance with some mixed signals, particularly in the weekly timeframe.

Read More

What does Shreyas Interm. do?

17-Jul-2025

Shreyas Intermediates Ltd manufactures dyes, pigments, and pigment intermediates in the Commodity Chemicals industry. As of March 2025, it reported a net profit of -3 Cr and has a market cap of INR 70 Cr.

Overview: <BR>Shreyas Intermediates Ltd is engaged in the manufacturing of Dyes, Pigments, and Pigment Intermediates within the Commodity Chemicals industry and operates as a Micro Cap company.<BR><BR>History: <BR>Shreyas Intermediates Ltd was incorporated as a Private Limited Company on November 6, 1989, and was converted into a Public Limited Company in April 1992. The latest quarterly results reported a net profit of -3 Cr for March 2025.<BR><BR>Financial Snapshot: <BR>Most recent Net Sales: N/A <BR>Most recent Net Profit: -3 Cr (Quarterly Results - Mar 2025) <BR>Market-cap value: INR 70 Cr (Micro Cap)<BR><BR>Key Metrics: <BR>P/E: N/A <BR>Industry P/E: 33 <BR>Dividend Yield: 0.00% <BR>Debt-Equity: 0.45 <BR>Return on Equity: -9.20% <BR>Price to Book: 4.04<BR><BR>Contact Details: <BR>Address: D-21 D-22 D-23 MIDC Inds Area, Lote Parshuram Taluka Khed Ratnagiri Maharashtra : 415722 <BR>Tel: 91-2356-272471 <BR>Email: accounts@shreyasintermediates.com <BR>Website: http://www.shreyaintermediates.co.in

Read More

Who are the top shareholders of the Shreyas Interm.?

17-Jul-2025

The top shareholders of Shreyas Interm. include Kesar Petroproducts Limited with 27.59%, Invent Assets Securitisation And Reconstruction Pvt Ltd at 24.7%, and foreign institutional investors holding 8.53%. Promoter holdings are partially pledged at 10.028%.

The top shareholders of Shreyas Interm. include Kesar Petroproducts Limited, which holds the highest promoter stake at 27.59%. Additionally, the highest public shareholder is Invent Assets Securitisation And Reconstruction Pvt Ltd, with a holding of 24.7%. The company also has foreign institutional investors (FIIs) holding 8.53%, while individual investors account for 7.67% of the shares. Promoter holdings are partially pledged at 10.028%.

Read More

How big is Shreyas Interm.?

24-Jul-2025

As of 24th July, Shreyas Intermediates Ltd has a market capitalization of 63.00 Cr and reported net sales of 0.00 Cr with a net loss of 1.57 Cr over the last four quarters. Shareholder's funds are valued at 17.98 Cr, and total assets amount to 25.76 Cr.

As of 24th July, <BR><BR>Market Cap: Shreyas Intermediates Ltd has a market capitalization of 63.00 Cr, classified as a Micro Cap.<BR><BR>Recent Quarterly Performance: The sum of Net Sales for the latest 4 quarters is 0.00 Cr, while the sum of Net Profit for the same period shows a loss of 1.57 Cr.<BR><BR>Balance Sheet Snapshot: The reporting period is the latest annual period ending March 2024. Shareholder's Funds are valued at 17.98 Cr, and Total Assets amount to 25.76 Cr.

Read More

When is the next results date for Shreyas Interm.?

07-Nov-2025

Shreyas Interm. will declare its results on 14 November 2025.

Shreyas Interm. will declare its results on 14 November 2025.

Read More

How has been the historical performance of Shreyas Interm.?

03-Dec-2025

Shreyas Interm. has consistently reported zero net sales and persistent losses from March 2019 to March 2025, with negative operating profits and declining book value per share, indicating ongoing financial struggles and lack of revenue generation. Total liabilities and assets have also decreased during this period.

Answer:<BR>The historical performance of Shreyas Interm. shows consistent figures across several key financial metrics, primarily indicating a lack of operational revenue and persistent losses over the years.<BR><BR>Breakdown:<BR>Shreyas Interm. has reported zero net sales and other operating income from March 2019 to March 2025, resulting in total operating income remaining at 0.00 throughout this period. The company has incurred minimal employee costs, which have slightly increased from 0.00 in March 2019 to 0.02 in March 2025, while other expenses have fluctuated, peaking at 0.54 in March 2020 before declining to 0.39 in March 2023 and 0.39 in March 2025. Operating profit (PBDIT) has been negative, with losses ranging from -0.17 in March 2019 to -0.41 in March 2025. Profit before tax and profit after tax have also shown consistent losses, with figures of -1.59 in March 2025, reflecting a trend of increasing losses over the years. The company's total liabilities decreased from 31.64 in March 2020 to 24.66 in March 2025, while total assets followed a similar downward trend, falling from 31.64 to 24.66 in the same period. The book value per share has also declined from 2.82 in March 2020 to 1.75 in March 2025, indicating a deterioration in shareholder value. Overall, Shreyas Interm. has struggled with profitability and asset management, maintaining a stagnant operational status with no revenue generation.

Read More

Should I buy, sell or hold Shreyas Interm.?

04-Dec-2025

Why is Shreyas Interm. falling/rising?

04-Dec-2025

As of 04-Dec, Shreyas Intermediates Ltd's stock price is at 10.30, reflecting a decline of 4.98% after two days of gains. The stock has underperformed its sector and shows significant year-to-date and one-year declines, indicating a shift in investor sentiment and reduced trading activity.

As of 04-Dec, Shreyas Intermediates Ltd's stock price is falling, currently at 10.30, which reflects a decrease of 0.54 or 4.98%. This decline follows a trend reversal after two consecutive days of gains. The stock has underperformed its sector by 4.23% today, indicating weaker performance compared to its peers. <BR><BR>Additionally, the stock has shown a significant decline over various periods, with a year-to-date drop of 21.19% and a one-year decrease of 27.72%. Although the stock had a notable increase of 38.63% over the past month, the recent performance suggests a shift in investor sentiment. <BR><BR>Investor participation has also decreased, as evidenced by a delivery volume of 5.22k on December 3, which is down by 28.21% compared to the five-day average. This reduction in trading activity may further contribute to the stock's downward pressure. Despite being above the 20-day, 50-day, 100-day, and 200-day moving averages, the stock is below its 5-day moving average, indicating a short-term weakness. Overall, these factors collectively explain the current decline in Shreyas Intermediates Ltd's stock price.

Read More
iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Dashboard
1

Weak Long Term Fundamental Strength with an average Return on Capital Employed (ROCE) of 0%

  • Poor long term growth as Operating profit has grown by an annual rate 2.37% of over the last 5 years
  • Low ability to service debt as the company has a high Debt to EBITDA ratio of -1.00 times
2

Risky - Negative EBITDA

3

Consistent Underperformance against the benchmark over the last 3 years

stock-summaryMojo Parameters
Mojo Parameters
Loading Valuation Snapshot...
Stock DNA
stock-summary
Industry

Commodity Chemicals

stock-summary
Market cap

INR 74 Cr (Micro Cap)

stock-summary
P/E

NA (Loss Making)

stock-summary
Industry P/E

35

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

0.49

stock-summary
Return on Equity

-7.84%

stock-summary
Price to Book

4.61

Revenue and Profits:
Net Sales:
10 Cr
(Quarterly Results - Sep 2025)
Net Profit:
0 Cr
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
Dividend Yield (0%)
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
30.43%
0%
30.43%
6 Months
9.87%
0%
9.87%
1 Year
-24.21%
0%
-24.21%
2 Years
-5.92%
0%
-5.92%
3 Years
-28.95%
0%
-28.95%
4 Years
51.9%
0%
51.9%
5 Years
15.76%
0%
15.76%

Shreyas Interm. for the last several years.

Risk Adjusted Returns v/s stock-summary
Returns Beta
Icon
Beta has not been calculated since enough price history is not available
stock-summaryNews & Corporate Actions
News
Announcements stock-summary

Announcement under Regulation 30 (LODR)-Newspaper Publication

17-Nov-2025 | Source : BSE

Newspaper Cuttings in connection with the Un-audited Financial Results for the quarter and half year ended 30.09.2025 in terms of Regulation 30 & 47 of SEBI (LODR) Regulatins 2015.

Board Meeting Outcome for Outcome Of The Board Meeting Held On 14/11/2025 And Submission Of Un-Audited Financial Results For The Quarter And Half Year Ended 30Th September 2025

14-Nov-2025 | Source : BSE

The Board of Directors in its meeting held on Friday 14th November 2025 at 4:00 p.m. have considered and approved the following: 1. Un-Audited Financial Results for the quarter and half year ended on 30th September 2025 along with Limited Review Report thereon. Kindly take the above in your records and acknowledge the receipt of the same. The Board Meeting concluded at 5:00 p.m.

Regulation 33 For The Quarter And Half Year Ended 30Th September 2025

14-Nov-2025 | Source : BSE

Pursuant to Regulation 33 of the SEBI (LODR) REgulation 2015 the board of Directors in their Meeting held on 14.11.2025 have approved the unaudited financial results of the company for the Quarter ended 30.09.2025 alongwith the limited review report thereon.

Corporate Actions stock-summary
stock-summary
BOARD MEETING

No Upcoming Board Meetings

stock-summary
DIVIDEND

No Dividend history available

stock-summary
SPLITS

No Splits history available

stock-summary
BONUS

No Bonus history available

stock-summary
RIGHTS

No Rights history available

stock-summaryKey Factors
Quality key factors stock-summary
Factor
Value
Sales Growth (5y)
77.64%
EBIT Growth (5y)
2.37%
EBIT to Interest (avg)
-2.05
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
0.49
Sales to Capital Employed (avg)
0.71
Tax Ratio
0
Dividend Payout Ratio
0
Pledged Shares
10.03%
Institutional Holding
8.42%
ROCE (avg)
-8.32%
ROE (avg)
0
Valuation key factors
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
35
Price to Book Value
4.61
EV to EBIT
-45.84
EV to EBITDA
-80.67
EV to Capital Employed
3.43
EV to Sales
4.83
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-7.49%
ROE (Latest)
-7.84%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Bullish
Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bullish
Bullish
Moving Averages
Mildly Bearish (Daily)
KST
Mildly Bullish
Bearish
Dow Theory
Mildly Bullish
No Trend
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Sep 2025stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Promoters

Pledged Promoter Holdings

10.028

Mutual Funds

Held by 3 Schemes (0.0%)

FIIs

Held by 1 FIIs (8.42%)

Promoter with highest holding

Kesar Petroproducts Limited' (27.59%)

Highest Public shareholder

Krish Pharma Speciality Private Limited (24.7%)

Individual Investors Holdings

7.76%

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Standalone) - Sep'25 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Sep 2025 is 64.08% vs 0.00% in Jun 2025",
        "dir": 1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "QoQ Growth in quarter ended Sep 2025 is 29.41% vs -13.33% in Jun 2025",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Sep'25",
        "Jun'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "10.37",
          "val2": "6.32",
          "chgp": "64.08%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "0.07",
          "val2": "-0.03",
          "chgp": "333.33%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "-0.24",
          "val2": "-0.34",
          "chgp": "29.41%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "0.68%",
          "val2": "-0.47%",
          "chgp": "1.15%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "half-yearly",
    "btn_text": "All Half Yearly Results",
    "header": "Half Yearly Results Snapshot (Standalone) - Sep'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": " Growth in half year ended Sep 2025 is 0.00% vs 0.00% in Sep 2024",
        "dir": 0
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": " Growth in half year ended Sep 2025 is 36.26% vs -8.33% in Sep 2024",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Sep'25",
        "Sep'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "16.69",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "0.04",
          "val2": "-0.30",
          "chgp": "113.33%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "-0.58",
          "val2": "-0.91",
          "chgp": "36.26%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "0.24%",
          "val2": "0.00%",
          "chgp": "0.24%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "nine-monthly",
    "btn_text": "All Nine Monthly Results",
    "header": "Nine Monthly Results Snapshot (Standalone) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in nine months ended Dec 2024 is 0.00% vs 0.00% in Dec 2023",
        "dir": 0
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "YoY Growth in nine months ended Dec 2024 is 11.81% vs -0.70% in Dec 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-0.38",
          "val2": "-0.43",
          "chgp": "11.63%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "-1.27",
          "val2": "-1.44",
          "chgp": "11.81%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "0.00%",
          "val2": "0.00%",
          "chgp": "NA",
          "chgp_class": "neutral"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Standalone) - Mar'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Mar 2025 is 0.00% vs 0.00% in Mar 2024",
        "dir": 0
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "YoY Growth in year ended Mar 2025 is -0.63% vs -0.64% in Mar 2024",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Mar'25",
        "Mar'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-0.41",
          "val2": "-0.39",
          "chgp": "-5.13%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "-1.59",
          "val2": "-1.58",
          "chgp": "-0.63%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "0.00%",
          "val2": "0.00%",
          "chgp": "NA",
          "chgp_class": "neutral"
        }
      ]
    }
  }
]
Quarterly Results Snapshot (Standalone) - Sep'25 - QoQstock-summary
Sep'25
Jun'25
Change(%)
Net Sales
10.37
6.32
64.08%
Operating Profit (PBDIT) excl Other Income
0.07
-0.03
333.33%
Interest
0.00
0.00
Exceptional Items
0.00
0.00
Standalone Net Profit
-0.24
-0.34
29.41%
Operating Profit Margin (Excl OI)
0.68%
-0.47%
1.15%
Values in Rs Cr.
Direction Arrows
Net Sales

QoQ Growth in quarter ended Sep 2025 is 64.08% vs 0.00% in Jun 2025

Direction Arrows
Standalone Net Profit

QoQ Growth in quarter ended Sep 2025 is 29.41% vs -13.33% in Jun 2025

Half Yearly Results Snapshot (Standalone) - Sep'25stock-summary
Sep'25
Sep'24
Change(%)
Net Sales
16.69
0.00
Operating Profit (PBDIT) excl Other Income
0.04
-0.30
113.33%
Interest
0.00
0.00
Exceptional Items
0.00
0.00
Standalone Net Profit
-0.58
-0.91
36.26%
Operating Profit Margin (Excl OI)
0.24%
0.00%
0.24%
Values in Rs Cr.
Net Sales

Growth in half year ended Sep 2025 is 0.00% vs 0.00% in Sep 2024

Direction Arrows
Standalone Net Profit

Growth in half year ended Sep 2025 is 36.26% vs -8.33% in Sep 2024

Nine Monthly Results Snapshot (Standalone) - Dec'24stock-summary
Dec'24
Dec'23
Change(%)
Net Sales
0.00
0.00
Operating Profit (PBDIT) excl Other Income
-0.38
-0.43
11.63%
Interest
0.00
0.00
Exceptional Items
0.00
0.00
Standalone Net Profit
-1.27
-1.44
11.81%
Operating Profit Margin (Excl OI)
0.00%
0.00%
NA
Values in Rs Cr.
Net Sales

YoY Growth in nine months ended Dec 2024 is 0.00% vs 0.00% in Dec 2023

Direction Arrows
Standalone Net Profit

YoY Growth in nine months ended Dec 2024 is 11.81% vs -0.70% in Dec 2023

Annual Results Snapshot (Standalone) - Mar'25stock-summary
Mar'25
Mar'24
Change(%)
Net Sales
0.00
0.00
Operating Profit (PBDIT) excl Other Income
-0.41
-0.39
-5.13%
Interest
0.00
0.00
Exceptional Items
0.00
0.00
Standalone Net Profit
-1.59
-1.58
-0.63%
Operating Profit Margin (Excl OI)
0.00%
0.00%
NA
Values in Rs Cr.
Net Sales

YoY Growth in year ended Mar 2025 is 0.00% vs 0.00% in Mar 2024

Direction Arrows
Standalone Net Profit

YoY Growth in year ended Mar 2025 is -0.63% vs -0.64% in Mar 2024

stock-summaryCompany CV
About Shreyas Intermediates Ltd stock-summary
stock-summary
Shreyas Intermediates Ltd
Micro Cap
Commodity Chemicals
Shreyas Intermediates Limited (SIL) was incorporated as a Private Limited Company on November 6, 1989 and subsequently converted into a Public Limited Company in April, 1992. The Company was promoted by Dinesh S Sharma. The Company is engaged in manufacturing of Dyes, Pigments and Pigment Intermediates.In Dec.'93, the company came out with its initial public offering, aggregating Rs 3.
Company Coordinates stock-summary
Company Details
D-21 D-22 D-23 MIDC Inds Area, Lote Parshuram Taluka Khed Ratnagiri Maharashtra : 415722
stock-summary
Tel: 91-2356-272471
stock-summary
accounts@shreyasintermediates.com
Registrar Details
Link Intime India Pvt Ltd, C-13 Pannalal Silk Compound, L B S Marg, Bhandup , Mumbai